Search results
Results From The WOW.Com Content Network
Johnson & Johnson updated its full-year guidance, predicting that it will book $88 billion to $88.4 billion in sales and adjusted-net income of $9.97 to $10.07 per share. The average-analyst ...
Johnson & Johnson On April 1, 2020, Johnson & Johnson stock was trading for $150 per share. In mid-July 2021, it’s up to $169, which is close to its 52-week high of $173.65.
Johnson & Johnson stock offers a 3.1% dividend yield at recent prices. The company has raised its dividend payout for 62 consecutive years and is in a better position to boost its payout now.
Year to date, the stock price is down 6.3% and has underperformed the S&P 500, which is up by 14.6% thus far. It's currently trading near its 52-week low, and it pays a fairly attractive dividend ...
Jennifer Taubert. Number of employees. 45.000. Parent. Johnson & Johnson. Website. janssen.com. Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split off its consumer healthcare business sector into a new publicly traded company, Kenvue.
At recent prices, the healthcare conglomerate offers a 3.2% yield, which is more than twice what you'd receive from the average stock in the benchmark S&P 500 index. Reasons to remain cautious
J&J (JNJ) to buy back $5 billion worth of shares. It also reaffirms its financial guidance for 2022.